Department of Radiation Oncology and Therapy, Jilin Provincial Key Laboratory of Radiation Oncology and Therapy, The First Hospital of Jilin University, Jilin, Changchun, 130000, China.
Department of Radiation Oncology and Therapy, Jilin Provincial Key Laboratory of Radiation Oncology and Therapy, The First Hospital of Jilin University, Jilin, Changchun, 130000, China; NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, 130021, China.
Biomed Pharmacother. 2021 May;137:111401. doi: 10.1016/j.biopha.2021.111401. Epub 2021 Mar 2.
Radiotherapy is one of the three main treatments for tumors. Almost 70% of tumor patients undergo radiotherapy at different periods. Although radiotherapy can enhance the local control rate of tumors and patients' quality of life, normal tissues often show radiation damage following radiotherapy. In recent years, several studies have shown that exosomes could be biomarkers for diseases and be involved in the treatment of radiation damage. Exosomes are nanoscale vesicles containing complex miRNAs and proteins. They can regulate the inflammatory response, enhance the regeneration effect of damaged tissue, and promote the repair of damaged tissues and cells, extending their survival time. In addition, their functions are achieved by paracrine signaling. In this review, we discuss the potential of exosomes as biomarkers and introduce the impact of exosomes on radiation damage in different organs and the hematopoietic system in detail.
放射治疗是肿瘤的三种主要治疗方法之一。几乎 70%的肿瘤患者在不同时期都接受放射治疗。虽然放射治疗可以提高肿瘤的局部控制率和患者的生活质量,但正常组织在放射治疗后往往会出现辐射损伤。近年来,几项研究表明,外泌体可以作为疾病的生物标志物,并参与放射损伤的治疗。外泌体是含有复杂 miRNA 和蛋白质的纳米级囊泡。它们可以调节炎症反应,增强受损组织的再生效果,促进受损组织和细胞的修复,延长其存活时间。此外,它们的功能是通过旁分泌信号传递来实现的。在这篇综述中,我们讨论了外泌体作为生物标志物的潜力,并详细介绍了外泌体对不同器官和造血系统辐射损伤的影响。